Comment
doi: 10.1016/S0140-6736(16)30372-5.
Epub 2016 Apr 28.
Vilanterol fluticasone and mortality in comorbid COPD GOLD B
Affiliations
- PMID: 27203487
- DOI: 10.1016/S0140-6736(16)30372-5
Item in Clipboard
Comment
Vilanterol fluticasone and mortality in comorbid COPD GOLD B
Lancet.
.
Erratum in
-
Department of Error.Lancet. 2016 May 7;387(10031):1908. doi: 10.1016/S0140-6736(16)30425-1. Lancet. 2016. PMID: 27203658 No abstract available.
No abstract available
Comment on
-
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.Lancet. 2016 Apr 30;387(10030):1817-26. doi: 10.1016/S0140-6736(16)30069-1. Epub 2016 Apr 28. Lancet. 2016. PMID: 27203508 Clinical Trial.
Similar articles
-
Breo Ellipta: An Inhaled Fluticasone/ Vilanterol Combination for COPD.Med Lett Drugs Ther. 2013 Sep 2;55(1424):69-71, 45-8. Med Lett Drugs Ther. 2013. PMID: 26839934 Review. English, French. No abstract available.
-
vilanterol + fluticasone (RELVAR Ellipta). Asthma and COPD: yet another beta-2 agonist and corticosteroid combination.Prescrire Int. 2016 Apr;25(170):94. Prescrire Int. 2016. PMID: 27186620
-
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.Lancet. 2016 Apr 30;387(10030):1817-26. doi: 10.1016/S0140-6736(16)30069-1. Epub 2016 Apr 28. Lancet. 2016. PMID: 27203508 Clinical Trial.
-
The lung study promising a breath of fresh air in research world.BMJ. 2015 Nov 27;351:h6343. doi: 10.1136/bmj.h6343. BMJ. 2015. PMID: 26613902 No abstract available.
-
A systematic review with meta-analysis of fluticasone furoate/vilanterol combination for the treatment of stable COPD.Pulm Pharmacol Ther. 2017 Feb;42:1-6. doi: 10.1016/j.pupt.2016.11.003. Epub 2016 Nov 15. Pulm Pharmacol Ther. 2017. PMID: 27864038 Review.
Cited by
-
Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.Cochrane Database Syst Rev. 2021 Jul 26;7(7):CD013384. doi: 10.1002/14651858.CD013384.pub2. Cochrane Database Syst Rev. 2021. PMID: 34309831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
